Comparing Glucose-Lowering Drugs for Type 2 Diabetes Treatment According to CVD Risk
In patients who have type 2 diabetes and low cardiovascular risk, receiving metformin as first-line therapy appears justified.
Home
Increasing Trends in Thyroid Cancer Burden Since 1990 Observed Worldwide
Increasing trends in global thyroid cancer burden were observed in a cross-sectional study using data from 195 countries in 21 regions.
First Oral Somatostatin Analog Approved for Acromegaly Treatment
The FDA has approved Mycapssa® (octreotide; Chiasma) capsules for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide.
Safety and Efficacy of Romosozumab Demonstrated in Postmenopausal Women With Mild to Moderate CKD
The safety and efficacy of romosozumab for osteoporosis treatment in postmenopausal women are not significantly affected by reduced kidney function.
Exclusive Breastfeeding May Prevent Weight Gain in At-Risk Children
Exclusive breastfeeding to 5 months can attenuate the impact of genetic risk on body mass index increase during childhood.
New Data Suggest 2 Distinct Subtypes of Polycystic Ovary Syndrome
A genetic analysis of nearly 900 women with polycystic ovary syndrome identified 2 distinct subtypes of the disease with unique genetic variants.
Heart Failure Linked to Highest Mortality Risk in Patients With Recent Type 2 Diabetes
Patients with type 2 diabetes have a greater risk for death after development of heart failure compared with other cardiovascular or renal diagnoses.
Statin Use May Benefit Patients Hospitalized With COVID-19
The use of statins appears to benefit patients hospitalized with COVID-19, according to the findings of a retrospective study conducted in Hubei Province, China.
Hand Osteoarthritis Associated With Changes in Bone Architecture and Strength
Researchers assessed the impact of primary hand osteoarthritis on bone mass, microstructure, and biomechanics in the affected skeletal regions.
Sugar-Sweetened Beverage Tax Expected to Generate Health Gains
Sugar-sweetened beverage tax designs are expected to generate substantial health gains and cost savings.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in General Endocrinology
